CAllWell it was a good call... I'm sure Schiff will give a more detailed reply to all the questions. I was impressed that they answered all of them and seemed to be open and honest with their replies. I can't say that I am happy with the fact that they haven't focused on a Cancer yet but their answer in that area was passable. It will all come down to Q1 and their decision... my impression is that they will test bladder until it is a go no go against ovarian. They are saying that it costs them little to pursue both at this time.
One little gem is that they have lots of news coming... lets hope the market likes it. Also, Stormont seems to be dedicated and though I asked if he would dump shares like last time he came across sincere in wanting this company to get to Phase I.... killing the SP would hurt him more than any of us.